Show simple item record

AuthorLin, Lisa
AuthorBarszczewski, Tiffany
AuthorBurgon, Patrick G.
AuthorTibbits, Glen F.
Available date2022-03-13T08:24:32Z
Publication Date2022-02-20
Publication NameHandbook of Stem Cell Therapy
Identifierhttp://dx.doi.org/10.1007/978-981-16-6016-0_44-1
CitationLin L., Barszczewski T., Burgon P.G., Tibbits G.F. (2022) Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) as a Platform for Modeling Arrhythmias. In: Haider K.H. (eds) Handbook of Stem Cell Therapy. Springer, Singapore. https://doi.org/10.1007/978-981-16-6016-0_44-1
ISBN978-981-16-6016-0
URIhttp://hdl.handle.net/10576/28038
AbstractCardiac arrhythmias can arise due to a host of both genetic and acquired factors. Specifically, the genetic basis of arrhythmogenesis is not fully understood due to the lack of robust models that reliably recapitulate human physiology. Human-induced pluripotent stem cells (hiPSCs) have strengthened regenerative medicine by producing cells that bear the genetic signature of patients being studied. Upon differentiation into hiPSC-derived cardiomyocytes (hiPSC-CMs), these cells can be used to phenotype known mutations or suspected variants that may contribute to abnormal electrical activity in the heart. Furthermore, novel therapeutics can be screened for the management and treatment of arrhythmias in patient-specific hiPSC-CMs. In this chapter, we will briefly discuss the practical utility of hiPSC- CMs to study inherited arrhythmias with a specific focus on atrial fibrillation (AF), catecholaminergic polymorphic ventricular tachycardia (CPVT), and disruptive electrical events that may occur in patients with hypertrophic cardiomyopathy (HCM). We will describe an investigative pipeline that integrates genome editing, tissue engineering, biobanking, and systems biology as complementary approaches. Together, these various applications are directed toward a common goal of bench-to-bedside characterization of arrhythmias in patient-specific hiPSC-CMs.
Languageen
PublisherSpringer Nature
SubjectArrhythmia
Cardiomyocytes
Cardiomyopathy
Fibrillation
hiPSCs
Pluripotent
TitleHuman-Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) as a Platform for Modeling Arrhythmias
TypeBook chapter
Pagination1-19
dc.accessType Full Text


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record